Review Article| Volume 41, ISSUE 1, P39-47, January 2023

Mohs Micrographic Surgery

Published:October 27, 2022DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Connolly S.M.
        • Baker D.R.
        • Coldiron B.M.
        • et al.
        AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery.
        J Am Acad Dermatol. 2012; 67: 531-550
        • Golda N.J.
        • Hruza G.J.
        Harmon C.B. Tolkachjov S.N. Mohs micrographic surgery from layers to reconstruction. 1st ed. Thieme, 2021 (Available at:) (Accessed December 19, 2021)
        • Tolkachjov S.N.
        • Brodland D.G.
        • Coldiron B.M.
        • et al.
        Understanding mohs micrographic surgery: a review and practical guide for the nondermatologist.
        Mayo Clin Proc. 2017; 92: 1261-1271
        • Perlis C.S.
        • Campbell R.M.
        • Perlis R.H.
        • et al.
        Incidence of and risk factors for medical malpractice lawsuits among mohs surgeons.
        Dermatol Surg. 2008; 32: 79-83
        • McGinness J.L.
        • Goldstein G.
        The value of preoperative biopsy-site photography for identifying cutaneous lesions.
        Dermatol Surg. 2010; 36: 194-197
        • Rowe D.E.
        • Carroll R.J.
        • Day C.L.
        Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
        J Dermatol Surg Oncol. 1989; 15: 424-431
        • Rowe D.E.
        • Carroll R.J.
        • Day C.L.
        Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection.
        J Am Acad Dermatol. 1992; 26: 976-990
        • Rowe D.E.
        • Carroll R.J.
        • Day C.L.
        Long-term recurrence rates in previously untreated (Primary) basal cell carcinoma: implications for patient follow-up.
        J Dermatol Surg Oncol. 1989; 15: 315-328
        • Randle H.W.
        • Zittelli J.
        • Brodland D.G.
        • et al.
        Histologic preparation for mohs micrographic surgery: the single section method.
        J Dermatol Surg Oncol. 1993; 19: 522-524
        • Hruza G.J.
        Mohs micrographic surgery local recurrences.
        J Dermatol Surg Oncol. 1994; 20: 573-577
        • Samie F.
        Surgeon error and slide quality during Mohs micrographic surgery: Is there a relationship with tumor recurrence?.
        J Am Acad Dermatol. 2021; 85: 538
        • Zabielinski M.
        • Leithauser L.
        • Godsey T.
        • et al.
        Laboratory errors leading to nonmelanoma skin cancer recurrence after mohs micrographic surgery.
        Dermatol Surg. 2015; 41: 913-916
        • Macdonald J.
        • Sneath J.R.
        • Cowan B.
        • et al.
        Tumor detection after inflammation or fibrosis on Mohs levels.
        Dermatol Surg. 2013; 39: 64-66
        • Stanoszek L.M.
        • Wang G.Y.
        • Harms P.W.
        Histologic Mimics of Basal Cell Carcinoma.
        Arch Pathol Lab Med. 2017; 141: 1490-1502
        • Karia P.S.
        • Jambusaria-Pahlajani A.
        • Harrington D.P.
        • et al.
        Evaluation of american joint committee on cancer, international union against cancer, and brigham and women’s hospital tumor staging for cutaneous squamous cell carcinoma.
        J Clin Oncol. 2014; 32: 327-334
        • Padgett J.K.
        • Parlette H.L.
        • English J.C.
        A diagnosis of chronic lymphocytic leukemia prompted by cutaneous lymphocytic infiltrates present in Mohs micrographic surgery frozen sections.
        Dermatol Surg. 2003; 29: 769-771
        • Mohs F.E.
        Chemosurgery for melanoma.
        Arch Dermatol. 1977; 113: 285-291
        • Zitelli J.A.
        • Mohs F.E.
        • Larson P.
        • et al.
        Mohs micrographic surgery for melanoma.
        Dermatol Clin. 1989; 7: 833-843
        • Rzepecki A.K.
        • Hwang C.D.
        • Etzkorn J.R.
        • et al.
        The rule of 10s versus the rule of 2s: High complication rates after conventional excision with postoperative margin assessment of specialty site versus trunk and proximal extremity melanomas.
        J Am Acad Dermatol. 2021; 85: 442-452
        • Demer A.M.
        • Hanson J.L.
        • Maher I.A.
        • et al.
        Association of mohs micrographic surgery vs wide local excision with overall survival outcomes for patients with melanoma of the trunk and extremities.
        JAMA Dermatol. 2021; 157: 84-89
        • Hanson J.
        • Demer A.
        • Liszewski W.
        • et al.
        Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision.
        J Am Acad Dermatol. 2020; 82: 149-155
        • Miller C.J.
        • Giordano C.N.
        • Higgins H.W.
        Mohs micrographic surgery for melanoma: as use increases, so does the need for best practices.
        JAMA Dermatol. 2019; 155: 1225-1226
        • Krausz A.E.
        • Higgins H.W.
        • Etzkorn J.
        • et al.
        Systematic review of technical variations for mohs micrographic surgery for melanoma.
        Dermatol Surg. 2021; 47: 1539-1544
        • Etzkorn J.R.
        • Sobanko J.F.
        • Elenitsas R.
        • et al.
        Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: Tissue processing methodology to optimize pathologic staging and margin assessment.
        J Am Acad Dermatol. 2015; 72: 840-850